Milestone Scientific opened lower at $0.29, compared with its previous close of $0.31. In the last trading session, the stock traded between $0.29 and $0.32. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Milestone Scientific is now worth
$ 12.23
Resulting in a loss of
$ 87.77 (87.77%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
$-0.02 (-6.04%)
Day High
$0.32
Day Low
$0.29
Day Open
$0.29
Prev Close
$0.31
Volume
1,38,161
1W Return
-9.63%
1M Return
-14.91%
3M Return
-40.61%
6M Return
-27.29%
1Y Return
-21.56%
Market Cap ($ Mn)
26
PE Ratio
-
PB Ratio
12.84
PEG Ratio
-
ROE
-150.60%
ROCE
-128.84%
EPS (TTM)
$-0.01
1 Week
-9.63%
1 Month
-14.91%
3 Months
-40.61%
6 Months
-27.29%
9 Months
9.32%
Milestone Scientific files prospectus to offer up to $45 million in securities
Milestone Scientific filed an SEC prospectus for a securities offering. The maximum value of the proposed offering is $45 million. The filing outlines the terms of the potential capital raise.
2mo agoMilestone Scientific converts $465k director loans to equity
Milestone Scientific Inc. (MLSS) converted $465,000 of director loans into equity. Three board members received 976,870 shares at $0.50 per share. Conversion price carried a 6.4% premium over the $0.47 market close. Transaction eliminates the company's outstanding note payable. Balance sheet is now debt-free as of August 19, 2026.
2mo agoMilestone Scientific Q3 Sales Guidance Misses $2.510M Estimate
Milestone Scientific (AMEX: MLSS) forecasts Q3 sales of $2.300 million-$2.500 million. This guidance misses the $2.510 million analyst estimate, with the upper limit falling short by $10,000.
3mo agoMilestone Scientific Q2 revenue up 22%; affirms FY26 guidance
Milestone Scientific reported Q2 2026 revenue of $2.841 million, up 22.3% YoY, driven by a 231% surge in medical division sales. The company narrowed its net loss to $(0.01) per share and reaffirmed its full-year 2026 revenue guidance of $9.8 million to $10.2 million, which matches the $9.910 million consensus estimate.
3mo agoMilestone Scientific signs federal distribution deal with Red One
Milestone Scientific Inc. has partnered with Red One Medical to distribute its CompuFlo Epidural System across US federal healthcare networks. The agreement targets the Department of Veterans Affairs and Department of Defense, which collectively serve over 18 million beneficiaries. While the deal opens significant commercial pathways, it does not guarantee specific contract awards or product adoptions.
3mo agoMilestone Scientific expects Q2 revenue of ~$2.8M, up 21% YoY
Milestone Scientific Inc. announced preliminary unaudited revenue for Q2 2026 of approximately $2.8 million, a 21% increase from the prior year, with H1 revenue rising 9% to $5.0 million. Growth was led by a 300% surge in the medical segment and international expansion, alongside progress in reimbursement claims.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in Milestone Scientific is now worth
$ 12.23
Resulting in a loss of
$ 87.77 (87.77%)
Note: Past profits do not guarantee future returns.
